Ana was Head, Development at Santhera Pharmaceuticals, and Head, Safety Due Diligence at Novartis. Ana De Vera joined NMD Pharma in 2025.
Ana De Vera is currently
Create your alert
to follow the career of Ana De Vera.
Do you need to know more about Ana De Vera? More results.
Report an error
Update the org chart details of Ana De Vera.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.